https://www.aicuris.com/
Homepage - Aicuris
Apr 16, 2026 - Delivering Novel Anti-Viral Therapies to patients with weakened immune systems We are driven to meet the needs of the growing population of immunocompromised pe
homepageaicuris
https://www.aicuris.com/clinical-trials/
Clinical Trials - Aicuris
Oct 16, 2025 - Clinical Trials Developing the Next Generation of Therapies to Combat Viral Infections At Aicuris, our commitment to pioneering therapies in infectious disease
clinical trialsaicuris
https://www.amrindustryalliance.org/member/aicuris-anti-infective-cures-gmbh-germany/
AiCuris Anti-infective Cures GmbH, Germany - AMR Industry Alliance
anti infectiveamr industryaicuriscuresgmbh
https://www.aicuris.com/press-release/aicuris-presents-positive-phase-2-results-for-pritelivir-and-favorable-phase-1-safety-data-for-aic468-at-id-week-2025/
Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data for...
Oct 20, 2025 - Aicuris today announced the presentation of new clinical data at ID Week 2025, highlighting progress across two key antiviral programs. Phase 2 results for prit
aicurispresentspositivephaseresults
https://www.aicuris.com/publications/
Publications - Aicuris
publicationsaicuris
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/biopharma-news/asahi-kasei-completes-acquisition-of-aicuris/
Asahi Kasei completes acquisition of Aicuris - European Pharmaceutical Manufacturer
Apr 20, 2026 - Asahi Kasei, a diversified global company, announced the successful completion of its acquisition of Aicuris Anti-infective Cures (Aicuris), a German-based...
asahi kaseicompletes acquisitioneuropean pharmaceuticalaicurismanufacturer
https://www.aicuris.com/products/
Products - Aicuris
productsaicuris
https://www.aicuris.com/press-release/aicuris-receives-fda-priority-review-for-pritelivir-nda-and-presents-new-phase-3-data-at-escmid-2026/
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID...
Apr 16, 2026 - Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026 Aicuris today announced that the U.S. Food and Drug Adminis
receives fdapresents newaicurispriorityreview
https://www.aicuris.com/press-release/aicuris-announces-pritelivir-phase-3-hsv-data-to-be-presented-as-late-breaking-oral-presentation-at-tandem/
Aicuris Announces Pritelivir Phase 3 HSV Data to Be Presented as Late-Breaking Oral Presentation at...
Jan 29, 2026 - Aicuris Announces Pritelivir Phase 3 HSV Data to Be Presented as Late-Breaking Oral Presentation at Tandem Aicuris will share Phase 3 data from for its lead can
late breakingaicurisannouncesphasehsv
https://www.aicuris.com/scientific-presentations/
Scientific Presentations - Aicuris
scientificpresentationsaicuris
https://www.aicuris.com/contact/
Contact - Aicuris
Mar 11, 2026 - Contact From concept to cure: advancing therapies to protect immunocompromised patients At Aicuris, we are committed to developing life-saving therapies for imm
aicuris
https://www.aicuris.com/about/
About - Aicuris
May 14, 2026 - About Addressing the critical needs of immunocompromised patients Company Overview Aicuris is at the forefront of developing innovative therapies to protect ind
aicuris
https://www.aicuris.com/privacy-notice/
Privacy Notice - Aicuris
Jan 15, 2026 - PRIVACY NOTICE Data protection is of high concern to Aicuris. For this reason, the processing of data from our website visitors, patients and customers in gener
privacy noticeaicuris
https://www.aicuris.com/imprint/
Imprint - Aicuris
Feb 25, 2025 - Imprint AiCuris Anti-infective Cures AG Friedrich-Ebert-Str. 475 Building 302 42117 Wuppertal Germany Phone +49 (0)202 317 63 - 0 Fax +49 (0)202 317 63 - 1177 M
imprintaicuris
https://www.aicuris.com/news-events/
News & Events - Aicuris
news eventsaicuris
https://www.aicuris.com/careers/
Careers - Aicuris
Feb 14, 2025 - Careers Join us in redefining the future of infection care Aicuris is dedicated to meeting the needs of the growing population of immunocompromised people who r
careersaicuris